tetracosactide
Small moleculeexperimental
Adrenocorticotropic hormone is used as a medication and as diagnostic agent in the ACTH stimulation test. — Wikipedia
Clinical trial activity
3 trials · 7 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
3
Phase 3
1
Phase 4
0
Earliest trial started Jul 1, 2008 (NCT00694863)
Timeline
Indications
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
Also known as
- tetracosactide hexaacetate
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03347526 | Phase 3 | Apr 19, 2018 | Pediatric Epilepsy Research Foundation, University of Colorado, University of Colorado, Denver, West Therapeutics, Inc |
| NCT03514589 | Phase 2 | Oct 12, 2012 | Sheffield Hallam University |
| NCT00694863 | Phase 2 | Jul 1, 2008 | Dutch Kidney Foundation, Radboud University |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (7)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Dutch Kidney Foundation | Academic/Hospital | 1 | 0 | 1 | 2008 |
| Pediatric Epilepsy Research Foundation | Academic/Hospital | 1 | 0 | 1 | 2018 |
| Radboud University | Academic/Hospital | 1 | 1 | 1 | 2008 |
| Sheffield Hallam University | Academic/Hospital | 1 | 1 | 1 | 2012 |
| University of Colorado | Academic/Hospital | 1 | 0 | 1 | 2018 |
| University of Colorado, Denver | Academic/Hospital | 1 | 1 | 1 | 2018 |
| West Therapeutics, Inc | For profit | 1 | 0 | 1 | 2018 |
7 organizations
Page 1 / 1